drugset / Trial / NCT03279341

Effect of PEG, Bisacodyl and Prucalopride on Colonic Motility in Healthy Subjects

NCT03279341

Phase 4 Completed 10 enrolled University Hospital, Gasthuisberg
RandomizedCrossoverDouble-blindOther

Summary

This study aim was to evaluate the effect of pharmacological treatments normally used to treat functional constipation and in particular PEG, bisacodyl and prucalopride on colonic motility as assessed by high-resolution manometry.

Timeline

Start
2012-12-03
Primary completion
2016-03
Completion
2016-03

Drugs

EvaluationDrugModalityDoseRoute
Comparator Bisacodyl Small molecule 10 mg Oral
Comparator Prucalopride Small molecule 2 mg Oral
Comparator polyethylene glycol Other / unclassified 13.8 g Oral

Indications